SYK Stryker Corp.

$SYK so my boss who has a big multi million dollar portfolio managed by this bollion dollar hedge fund put this into his portfolio last month. I was thinking going half or 75% full port. Any idea why I shouldnt?

$SYK Bought 150 shares for my son in his account and 200 shares for myself. What a great bargain!

$SYK down about 13% after hours. Stryker is medtech, not even an AI stock, and it still lost double digits after hours. this selloff is not checking tickers

Nice win in $SYK today. I think I’ll play this for awhile, need to study the covered call market. Can’t stand making too much here.

$SYK The 293 million dollar goodwill impairment in Q3 came from one reporting unit. Note 11 puts it in Peripheral Vascular, after forecast cash flows were cut on near-term operational and supply constraints and a longer expected period to reach the anticipated growth. That unit holds Inari, bought in February 2025 for 4,810 million dollars with 3,117 million of that in goodwill, and Stryker added AVS to the same unit in May this year. Pretty quick for a unit still being built by acquisition to fail an interim test.

$SYK This has been on my watchlist. Surprised by the reaction to the earnings. Starter soon.

$SYK Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $3.52 up 10.34% YoY • Reported revenue of $6.52B up 7.64% YoY • Stryker is updating full year 2026 guidance to organic net sales growth of 6.5% to 7.0% and adjusted diluted EPS of $14.80 to $14.90; sales guidance includes modestly positive pricing impact.

$SYK reports earnings today after the close. I’m bullish heading into the report: SYK has beaten EPS estimates in 7 of its last 8 reports, according to Stock Meadow.

Stryker Stock In Focus As Truist Says CEO Transition Is Low-Risk, Cuts Price Target To $310 $SYK https://stocktwits.com/news/equity/markets/stryker-stock-in-focus-as-truist-says-ceo-transition-is-low-risk-cuts-price-target-to-310/cZDtfVSRBlf